These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

750 related items for PubMed ID: 17661146

  • 1. Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection.
    Yasuda K, Inomata M, Shiromizu A, Shiraishi N, Higashi H, Kitano S.
    Dis Colon Rectum; 2007 Sep; 50(9):1370-6. PubMed ID: 17661146
    [Abstract] [Full Text] [Related]

  • 2. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL, Chang SC, Lin JK, Wang HS, Yang SH, Jiang JK, Chen WC, Lin TC.
    Hepatogastroenterology; 2005 Sep; 52(66):1688-91. PubMed ID: 16334758
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
    Hanaoka N, Tanabe S, Mikami T, Okayasu I, Saigenji K.
    Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
    [Abstract] [Full Text] [Related]

  • 8. Location of early colorectal cancers at fold-top may reduce the risk of lymph node metastasis.
    Pan W, Terai T, Abe S, Sakamoto N, Nagahara A, Ohkusa T, Ogihara T, Sato N.
    Dis Colon Rectum; 2006 May; 49(5):579-87. PubMed ID: 16583291
    [Abstract] [Full Text] [Related]

  • 9. The lymphatic infiltration identified by D2-40 monoclonal antibody predicts lymph node metastasis in submucosal invasive colorectal cancer.
    Kawaura K, Fujii S, Murata Y, Hasebe T, Ishii G, Itoh T, Sano Y, Saito N, Ochiai A.
    Pathobiology; 2007 May; 74(6):328-35. PubMed ID: 18087197
    [Abstract] [Full Text] [Related]

  • 10. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer.
    Yabushita H, Shimazu M, Yamada H, Sawaguchi K, Noguchi M, Nakanishi M, Kawai M.
    Gynecol Oncol; 2001 Feb; 80(2):139-44. PubMed ID: 11161851
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study.
    Chen G, McIver CM, Texler M, Lloyd JM, Rieger N, Hewett PJ, Sen Wan D, Hardingham JE.
    Dis Colon Rectum; 2004 May; 47(5):679-86. PubMed ID: 15037935
    [Abstract] [Full Text] [Related]

  • 13. Tumor budding as an indicator of isolated tumor cells in lymph nodes from patients with node-negative colorectal cancer.
    Park SY, Choe G, Lee HS, Jung SY, Park JG, Kim WH.
    Dis Colon Rectum; 2005 Feb; 48(2):292-302. PubMed ID: 15616755
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma.
    Yano H, Saito Y, Kirihara Y, Takashima J.
    Dis Colon Rectum; 2006 Dec; 49(12):1867-77. PubMed ID: 17080279
    [Abstract] [Full Text] [Related]

  • 17. Involvement of cyclooxygenase-2 and vascular endothelial growth factor in vascularization and lymph node metastasis of colorectal cancers with submucosal invasion.
    Abe A, Fukui H, Fujii S, Fujita M, Mukawa K, Ichikawa K, Tomita S, Ono Y, Imai Y, Imura J, Kubota K, Fujimori T.
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1071-7. PubMed ID: 17608853
    [Abstract] [Full Text] [Related]

  • 18. Lymphatic vessel density at the site of deepest penetration as a predictor of lymph node metastasis in submucosal colorectal cancer.
    Kaneko I, Tanaka S, Oka S, Kawamura T, Hiyama T, Ito M, Yoshihara M, Shimamoto F, Chayama K.
    Dis Colon Rectum; 2007 Jan; 50(1):13-21. PubMed ID: 17115337
    [Abstract] [Full Text] [Related]

  • 19. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.
    Ogawa T, Yoshida T, Tsuruta T, Tokuyama W, Adachi S, Kikuchi M, Mikami T, Saigenji K, Okayasu I.
    Scand J Gastroenterol; 2009 Jan; 44(5):605-14. PubMed ID: 19221929
    [Abstract] [Full Text] [Related]

  • 20. Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas.
    Masaki T, Matsuoka H, Sugiyama M, Abe N, Sakamoto A, Atomi Y.
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1115-21. PubMed ID: 16824062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.